Angioimmunoblastic T-cell lymphoma initially presenting with replacement of bone marrow and peripheral plasmacytosis

Internal Medicine

Volumn 46, Issue 7, 2007, Pages 419-424

  Sakai, Hisashi ^a   Tanaka, Hideaki ^a   Katsurada, Tatsuya ^a   Yoshida, Yataro ^a   Okamoto, Eiichi ^a   Ohno, Hitoshi ^a  

^a TAKEDA GENERAL HOSPITAL   (Japan)

Author keywords

Angioimmunoblastic T cell lymphoma; Bone marrow replacement; CD10+ T cell; Immunohistochemistry; Plasma cell

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; NITROGEN; PREDNISOLONE; UREA; URIC ACID;

ABDOMINAL DISTENSION; AGED; ANEMIA; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; AUTOPSY; BLOOD PRESSURE; BONE MARROW CELL; CANCER GROWTH; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FATIGUE; FEVER; FLOW CYTOMETRY; HEMATOLOGIC DISEASE; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKOCYTOSIS; LYMPH NODE BIOPSY; MALE; PATIENT REFERRAL; PETECHIA; PLASMACYTOSIS; PROTEIN BLOOD LEVEL; T CELL LYMPHOMA; THROMBOCYTOPENIA;

AGED; AUTOPSY; BIOPSY, NEEDLE; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, PERIPHERAL; MALE; PLASMA CELLS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 34247146927     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6121     Document Type: Article

References (12)

1. Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1: 1070-1073, 1974.
2. Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 121: 681-691, 2003.
3. Jaffe ES, Ralfkiaer E. Angioimmunoblastic T-cell lymphoma. in: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW, Eds. IARC Press, Lyon: 225-226, 2001.
4. Merchant SH, Amin MB, Viswanatha DS. Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: emphasis on phenotypic aberrancies for early diagnosis. Am J Clin Pathol 126: 1-10, 2006.
5. Ghani AM, Krause JR. Bone marrow biopsy findings in angioimmunoblastic lymphadenopathy. Br J Haematol 61: 203-213, 1985.
6. Dogan A, Morice WG. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematol 127: 140-154, 2004.
7. Pautier P, Devidas A, Delmer A, et al. Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32: 545-552, 1999.
8. Attygalle AD, Diss TC, Munson P, Isaacson PG, Du MQ, Dogan A. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 28: 54-61, 2004.
9. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99: 627-633, 2002.
10. Jego G, Robillard N, Puthier D, et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 94: 701-712, 1999.
11. Hsu SM, Waldron JA Jr, Fink L, et al. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Hum Pathol 24: 126-131, 1993.
12. Higuchi T, Mori H, Niikura H, Omine M. Hypocomplementemia. and hematological abnormalities in immunoblastic lymphadenopathy and immunoblastic lymphadenopathy-like T cell lymphoma. Acta Haematol 96: 68-72, 1996.